SCHEDULE 13G - ACADIA PHARMACEUTICALS

Company

ACADIA PHARMACEUTICALS INC

Filed

March 19, 2007

Accession Number

0000932440-07-000223

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →